These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33438236)

  • 1. Iatrogenic cutaneous lymphoid hyperplasia induced by squaric acid dibutyl ester.
    Takahagi S; Numata T; Tanaka A; Hide M
    Contact Dermatitis; 2021 Jul; 85(1):88-90. PubMed ID: 33438236
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
    Stinco G; Patrone P
    Contact Dermatitis; 2000 Jul; 43(1):52-3. PubMed ID: 10902598
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent allergic contact dermatitis at the site of primary sensitization with squaric acid dibutyl ester.
    Nasca MR; Cicero RL; Innocenzi D; Micali G
    Contact Dermatitis; 1995 Dec; 33(6):438. PubMed ID: 8706413
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
    Giannetti A; Orecchia G
    Dermatologica; 1983; 167(5):280-2. PubMed ID: 6653853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
    Ujiie H; Sawamura D; Shibaki A; Shimizu H
    Clin Exp Dermatol; 2005 Sep; 30(5):579-80. PubMed ID: 16045698
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent allergic contact dermatitis from squaric acid dibutyl ester.
    Fowler JF; Hodge SJ; Tobin GR
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):259-60. PubMed ID: 8432926
    [No Abstract]   [Full Text] [Related]  

  • 7. Iatrogenic benign lymphoplasia induced by allergic contact dermatitis from squaric acid dibutylester: immunohistologic study of cellular infiltrates.
    Nishioka K; Ogasawara M; Kurata K; Asagami C
    Contact Dermatitis; 1993 Jan; 28(1):3-5. PubMed ID: 8428442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effects during treatment with SADBE.
    Frattasio A; Germino M; Cargnello S; Patrone P
    Contact Dermatitis; 1997 Feb; 36(2):118-9. PubMed ID: 9062760
    [No Abstract]   [Full Text] [Related]  

  • 9. Squaric acid dibutyl ester in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    Dermatologica; 1985; 170(1):40-2. PubMed ID: 3882480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topical therapy of alopecia areata with squaric acid dibutyl ester].
    Morishita M; Nagai T; Sato Y
    Nihon Hifuka Gakkai Zasshi; 1987 Jan; 97(1):61-4. PubMed ID: 3573366
    [No Abstract]   [Full Text] [Related]  

  • 11. Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
    Valsecchi R; Cainelli T
    Contact Dermatitis; 1985 Apr; 12(4):234. PubMed ID: 4017578
    [No Abstract]   [Full Text] [Related]  

  • 12. An answer to some questions raised by skin reactions observed during squaric acid dibutylester contact sensitization.
    Happle R
    Contact Dermatitis; 2001 Sep; 45(3):189-90. PubMed ID: 11553162
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical sequelae associated with squaric acid dibutylester topical sensitization.
    Foley S; Blattel SA; Martin AG
    Am J Contact Dermat; 1996 Jun; 7(2):104-8. PubMed ID: 8796751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A; Mato F; Quiñones PA
    Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
    Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G
    G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
    [No Abstract]   [Full Text] [Related]  

  • 17. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.
    Guerra L; Pacifico V; Calabresi V; De Luca N; Castiglia D; Angelo C; Zambruno G; Di Zenzo G
    Br J Dermatol; 2017 Feb; 176(2):491-494. PubMed ID: 27208509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata.
    Napolitano M; Cantelli M; Vastarella M; Nappa P; Fabbrocini G; Patruno C
    Contact Dermatitis; 2019 Jul; 81(1):67-68. PubMed ID: 30663070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.